Structure Current Deferred Revenue vs Short Term Debt Analysis
| GPCR Stock | 53.07 2.56 4.60% |
Structure Therapeutics financial indicator trend analysis is much more than just breaking down Structure Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Structure Therapeutics is a good investment. Please check the relationship between Structure Therapeutics Current Deferred Revenue and its Short Term Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Current Deferred Revenue vs Short Term Debt
Current Deferred Revenue vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Structure Therapeutics Current Deferred Revenue account and Short Term Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Structure Therapeutics' Current Deferred Revenue and Short Term Debt is -0.94. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Structure Therapeutics American, assuming nothing else is changed. The correlation between historical values of Structure Therapeutics' Current Deferred Revenue and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Structure Therapeutics American are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Current Deferred Revenue i.e., Structure Therapeutics' Current Deferred Revenue and Short Term Debt go up and down completely randomly.
Correlation Coefficient | -0.94 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Short Term Debt
Most indicators from Structure Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Structure Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Structure Therapeutics' Tax Provision is relatively stable compared to the past year. As of 06/09/2024, Selling General Administrative is likely to grow to about 34.3 M, while Enterprise Value Multiple is likely to drop (14.17).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 122.2K | 1.5M | 13.4M | 14.1M | Depreciation And Amortization | 72.0 | 277K | 949.2K | 996.6K |
Structure Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Structure Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.